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Abstract: Tissue-culture adaptation of viruses can modulate infection. Laboratory passage and
bacterial artificial chromosome (BAC)mid cloning of human cytomegalovirus, HCMV, resulted in
genomic deletions and rearrangements altering genes encoding the virus entry complex, which
affected cellular tropism, virulence, and vaccine development. Here, we analyse these effects on the
reference genome for related betaherpesviruses, Roseolovirus, human herpesvirus 6A (HHV-6A)
strain U1102. This virus is also naturally “cloned” by germline subtelomeric chromosomal-integration
in approximately 1% of human populations, and accurate references are key to understanding
pathological relationships between exogenous and endogenous virus. Using whole genome
next-generation deep-sequencing Illumina-based methods, we compared the original isolate to
tissue-culture passaged and the BACmid-cloned virus. This re-defined the reference genome showing
32 corrections and 5 polymorphisms. Furthermore, minor variant analyses of passaged and BACmid
virus identified emerging populations of a further 32 single nucleotide polymorphisms (SNPs) in
10 loci, half non-synonymous indicating cell-culture selection. Analyses of the BAC-virus genome
showed deletion of the BAC cassette via loxP recombination removing green fluorescent protein
(GFP)-based selection. As shown for HCMV culture effects, select HHV-6A SNPs mapped to genes
encoding mediators of virus cellular entry, including virus envelope glycoprotein genes gB and the
gH/gL complex. Comparative models suggest stabilisation of the post-fusion conformation. These
SNPs are essential to consider in vaccine-design, antimicrobial-resistance, and pathogenesis.
Keywords: human herpesvirus; HHV-6; HHV-6A; Roseolovirus; betaherpesvirus; virus entry
complex; gH/gL; gB; deep sequencing; reference genome; cell fusion; glycoprotein structure model
1. Introduction
Establishing reference genomes are essential for characterisation of pathogens, their interaction
with the host, development of vaccines, and responses to therapies including antimicrobial resistance.
Betaherpesviruses are a classic example of effects of laboratory passage of viruses distorting
understanding of natural transmission. In this case, betaherpesvirus human cytomegalovirus (HCMV)
was originally cultured in human fibroblasts, the reference AD169 strain, with derivation of its genome
being the largest at the time [1]. However, increasing evidence showed differences with strains
grown in endothelial cells, the cell type relevant for characterising one of the main pathologies of
the virus and placental infection causing congenital disease with cytomegalovirus (CMV) the main
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infectious cause of birth defects, including microcephaly even in the setting of emergent Zika virus.
Derivation of the genomic sequence of early passage clinical strains showed that an almost 20kb
deletion occurred in the AD169 genome [2]. Subsequent extensive analyses, using next generation
sequencing technologies, have shown that clinical isolates, which are not cultured, do not have this
deletion. Furthermore, genes located in the “deleted” region encoded essential elements dictating
the cellular tropism of the virus. Alternate gH/gL complexes were established as main components
of cellular tropism and fusogenic entry of the virus into cells. The trimer, gH/gL/gO, related to
fibroblastic entry of cells while the competing pentamer form gH/gL/UL128/UL130/UL131 dictated
endothelial, leukocyte, and epithelial cell entry [3]. The pentameric components were encoded
by genes in the “deleted” region of the genomes of laboratory-passaged virus. bacterial artificial
chromosome (BAC)mid “repair” of these genes rescued infection defects, but also could be mutagenic
themselves, if there were single nucleotide polymorphisms (SNPs) affecting efficiency of tissue culture
replication [4]. The resulting complexity of these components are essential to vaccine design and
generation of a neutralising antibody, even to new vaccine vectors directed at other infections and
modulating cellular immunity [5–7]. These could never have been identified without the derivation of
the actual wild type genomes involved in natural transmission.
Similar analyses of polymorphisms in the reference human betaherpesvirus 6, HHV-6A, have not
yet been conducted. However, isolated reports indicate homologous regions are targeted and may
also occur in virus replicated in vivo. HHV-6A also encodes a gH/gL complex central to infectious
entry, as well as alternate multimeric complexes affecting cellular tropism; these are a related trimeric
complex gH/gL/gO and a quadrameric complex gH/gL/gQ1/gQ2 [8–11]. The gQ1 and gQ2 genes
are in the homologous pathogenicity region to that in HCMV. Polymorphisms in gQ2 have similarly
been detected in tissue culture passaged virus as well as in a BACmid clone of human herpesvirus 6A
(HHV-6A) strain U1102 [12]. Furthermore, there is a positional homologue of HCMV chemokine like
molecules UL128/130/131, which is HHV-6A chemokine U83A [13]. Polymorphisms in HHV-6 strain
U1102 virus passaged in vitro as well as in vivo strains have been reported, which affect translated
reading frames of this gene, alternating between an extended encoded mature secreted chemokine
and a non-secreted version [13,14]. In addition, a few corrections have been reported, including a CG
inversion in U83A [15], GG insertions in DR6 [16], and nucleotide insertion in U86 [17]. Two distinct
but closely related genomes of HHV-6A strain GS have been reported (HHV-6A GS KJ123690.1 and
KC465951.1), indicating potential for virus population polymorphisms; however, initial reports of this
strain as a human B-lymphotropic virus (HBLV) describes isolation from six patients, therefore, there
could be mixtures [18]. A systematic analysis has not been undertaken to evaluate in the type reference
genome of HHV-6, HHV-6A strain U1102, populations of viruses generated from tissue culture passage
or present from in vivo polymorphisms. This is essential to understanding the pathogenicity of HHV-6
as a HCMV.
Human herpesviruses cause a range of pathologies from oral diseases, incurable genital infections,
to cancers. HHV-6A is linked with neurological and cardiac disorders in immune suppressed or naive
patients [19], including fatal infant myocarditis [20,21]. Roseoloviruses, mainly HHV-6A and HHV-6B,
are unique among human herpesviruses in integrating their genome in the human germline at the
chromosomal telomere, termed CiHHV6A and CiHHV6B. This affects approximately 1% of people
worldwide—there are upwards of 70 million people at risk of virus reactivation in every cell, and recent
studies show links with impaired infant neurodevelopment and cardiac disease [14,22–25]. Genomic
studies show the reference HHV-6A distinct from CiHHV6A, but the full extent of polymorphisms
in the reference strain are required to understand relationships with CiHHV6A in order to interpret
clinical conditions and potential treatment for virus reactivation.
Our studies using deep sequencing showed we could distinguish between known circulating
HHV-6A viruses and those that are integrated in our genomes, CiHHV-6A [14,24]. With next generation
sequencing technologies, we could amplify specifically the virus sequences separate from the human
genome in order to characterise their differences. We combined this method with whole genome deep
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sequencing, where the short reads map to a reference template genome and are amplified thousands
of times, which enables rare mutations in a population to be detected. We can significantly detect these
“minor variants” down to 1% in a mixture and have used this method to detect minor variants from
virus superinfection. Viruses superinfecting patients with integrated genomes were detected as 1–30%
mixtures by using SNPs representative of superinfecting virus genomes [24].
This methodology was applied here to redefine the Roseolovirus type reference, HHV-6A strain
U1102, using an early isolate and to characterise population polymorphisms and minor variants arising
from effects of tissue culture passage of virus and in BACmid virus reconstruction. This was done
in order to test whether the same mutagenic effects on the virus entry complex as shown for HCMV
were also affected in HHV-6A. We further validate these polymorphisms by reference to in vivo virus
“cloned” by integration in the germline. This not only defines the reference but also the changes critical
to virus spread during cell culture that are relevant to general understanding of infection mechanisms.
2. Materials and Methods
2.1. Cells and Viruses
HHV-6A strain U1102 low passage from the original isolate, P3, was grown in JJhan cells as
described [26]. The continuous cultured virus, termed pU1102 here, was grown on HSB2 cells (Kindly
donated by B. Prusty from the University of Wurzberg, Würzburg, Germany) and a virus reconstructed
from cloned BACmid version BAC-U1102 (kindly provided by Y. Mori, Kobe University, Japan and
cultured by B. Prusty, University of Wurzberg, Würzburg, Germany) [12,27] were identically passaged
in HSB2 cells, as described, for four serial weekly passages [28,29]. CiHHV-6A strains 5055, 2284,
and 5814 were extracted from DNA from patients as described in [24].
2.2. Illumina Deep Sequencing
The five virus-infected cell DNA samples were extracted (Qiagen, Hilden, Germany) and
CiHHV6A DNAs were prepared for target enrichment amplification and deep sequencing as described.
These were HHV-6A U1102, bU1102, BAC-U1102, K21-HHV-6A-pU1102, and K21 BAC-U1102. For the
specific amplification, 36 overlapping primer pairs were used which amplified overlapping PCR
products across the complete genome as described, with all predicted sizes amplified (see primers
in Table 1). These were separated by agarose gel electrophoresis, and the purified products pooled
in equal quantities as measured using Qubit. Libraries were prepared by sonicating the DNA using
Covaris, followed by purification and random PRC amplification using adaptor tags from the NEBNext
DNA library kit. Tagged samples were run on a MiSeq and the resulting raw FASTQ files analysed after
quality assessment and removal of adaptor tags and primer sequences as we described previously [24].
The reads were trimmed using trimmomatic with quality scores applied, then assembled
using Samtools and Burrow-Wheeler Aligner (BWA)-mem alignment algorithm by mapping to
reference genomes using the HHV-6A U1102 reference genome (updated from denovo assemblies)
as described [24]. Coverage and qualities were assessed using BAC-U1102 complete coverage as a
template. Contigs were ordered using the reference genome with manual adjustment using Artemis.
Variant calling was applied with both Genome Analysis Toolkit (GATK) UnifiedGenotyper and
SAMtools mpileup using BCFtools, vcfutils varFilter pipeline, quality scores >25, and minimum read
depths of 10 for base call accuracy [24,29].
The rapid annotations tool Rapid Annotation Transfer Tool (RATT) was used to transfer
annotations and syntenic coordinates from the reference genome [30] (HHV-6 U1102 NC_001664). All
SNPs were compiled and compared in an excel database using a custom python script. Tables were
tabulated for corrections and polymorphisms. All SNPs from K21 treated samples were compared
using the unexposed HHV-6A pU1102 and BAC-U1102 samples as template. Average coverage was
2000–10,000 reads depth with a sensitivity variant cut-off of 1%. All results using target amplification
were compared to those generated via SureSelect (Agilent, Santa Clara, CA, USA) enrichment and de
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novo assembly as described [31], and were in agreement with no evidence for gaps. The re-defined
reference genome is deposited for European Bioinformatics Institute (EBI) (updated to the original
deposition X83413) and Genbank (reference genome NC_001664).
Table 1. Long range PCR genome amplicon primers.
Amplicon Forward Primer (5′-3′) Reverse Primer (5′-3′) Size (bp)
DR1 ACAACCGCATCTTCTTCAG ATGAACGGAGATCTGGGAG 1750
DR1DR6 CCTCATCTGTTATTCCCTTCC ACTCACCGCAGTCTTGAAC 2872
DR6 TCCAAACTGTACGGCTATG TGGCGTCTAATCCAGGTAC 1858
DR_UL CATGAGAGGACACTGGACGTACTC GACATCTGTGGACCATGCA 2339
0203 ACCATGTGCGGAGAAAGTTG ACGAGAATGAATATGCCGATG 2174
0306 ACTCCTATCCGTCTAAACTGCT ATTTCTCACGCCGGTATTC 4417
0611 ATGCCAAATCTAGCTGCTG GAATCGGAGGAAGCTAACGT 4757
1114 TCTTCAGGTGTCTCAACCTTC TGATGATCTGCTGTTGGAAC 5737
1419 TTGAGATGCAGAGCCTCTC ACGTGGTGGATAATTCTTCAG 5370
1923 CTACATCATCGGTTGCCATA TACAGAAGTTTCGGCAACTG 5216
2328 TAGTCGCTGGATGTCGATAC GAGGAATTGTGGACAACGCT 4721
2830 CATCCAACTCCTTGTCCGT TCGTTCGACGTGTCTGAC 5753
3031 GACACTGTCCAACGCATCT CTCTTGGGCATAAGTCCAGTA 6552
3134 ACAGAGCGACACCCAATATTC AGCTGTGTCGATGTCTTGCTA 2787
3439 TGCATTCTCTCACAGCATG TGTTTCCTTATGCCACCAATC 6309
3941 TGAGGCATGAGACTCAGAAG AGCGGCATCCATAATGCTTA 4796
4142 AGCATCGTTTGAAGACACC GAGTTGTTGTTCGCTGGTCT 2810
4142INT TTGTTTCAGGCCAGCATC ATACCGAAAACTCAGGCAAC 2983
4245 AGACCGCATTCGTATCGCT CACGATCAAGTTCGAATCGTA 5092
4549 GAGTGCTCGGATAAGTTCATT ACGATACAATCCGGAATGC 5922
4953 TGGAACTCGGAATTGTTTCT GTTTGAGACTGTATCTGCGCA 4282
5357 TATGGTGAAGAACCGTCG TCCGCAGATAACAGAATGG 4707
5758 CAGTGCCATCTGTTATGAATAG AGTCGCAGTAAGGTCCACGT 6792
5864 TGCTGAAATTACCTCAGTGAG CCATTCAGTATAATGCATCC 4229
6469 CTGTATCAATATCAAGGCGG ACCACTGAATACGAACGCTC 5111
6974 GCGATTGTTCTGCGATAGAG CTTATATCCGAGCCTTGCAGT 6472
7476 GAGAACATGCTAGACAATTGG CAAGAACTGCGACTCAATCC 2668
7679 GTTGCTAGTTGTATGACTTGG CAATATCCACCGTTAGAGAAC 7681
7984 AGATGTATGCTGAAGAACGTG GGATCGTCAACCGTTAGTG 5109
8486 CACAGTGTGTTCGCCGGAAG ACAGACAATGCACATCCTCTG 4773
8690 AGGTTGATACGGCAACGAG GCAATCATTAGCATACAGATG 3326
8690INT TGAGGAATCACGTGTTTG ATCGAATCTATCCATGAAGATG 1746
90R3 CATCATTGTTATCGCTTTCAC GCAACCGCAGTTCCTGTT 4912
R395 GCGGTACCCACTGATCTT AGTCTACCAGGCATTCCGT 6250
95100 GAGGAGGGTCTGTCTAGATGT TCGGAGATATCATAATCTGCGT 4031
100DR TTATAGTTGCTCCCGAAAGC AAGAAGATGCGGTTGTCTTG 2358
2.3. Molecular Models
Comparative models were generated for HCMV gB from strain Merlin (UniProtKB/Swiss-Prot:
F5HB53) and for HHV-6A U1102 gB from wt and passaged strains in the post-fusion conformation
using Modeller9v7 [32]. The modelling was based on multiple templates from gB HCMV strain
AD169 (PDB ID: 5cxf) and strain Towne (PDB ID: 4osn and 5c6t), gB Epstein-Barr virus (EBV) strain
B95-8 (PDB ID: 3fvc), and gB Herpes Simplex virus (HSV)-1, strain KOS (PDB ID: 2gum and 3nwa).
Closest alignments were shown with HCMV gB, 45% identity, 65% similarity (meta method M-Coffee,
see Supplymentary Materials Figures S1–3). The models cover the ectodomain, residues 38–579,
and domains I, II, III, and IV. The passage mutant, Thr193Ala, was modelled using swapaa command
in Chimera [32]. The models of the HHV-6A gB trimer for the domain I of wt, and passage mutant,
Thr193Ala, gB were obtained by structural alignments with the structure of the gB HCMV trimer strain
AD169 (PDB ID: 5cxf) with each of its subunits. The free energy predictions of the Thr193Ala mutation
on the subunit-subunit interaction stability was done using web server mCSM [33], which predicts
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stability changes of a wide range of mutations from graph-based signatures encoding distance patterns
between atoms.
3. Results
3.1. Deep Sequence Analyses of Reference HHV-6A Strain U1102 Shows Corrections
Illumina deep sequencing was conducted deriving HHV-6A strain U1102 genomes between
2000–10,000 times per group. These included three versions of HHV-6A strain U1102: low passage (P3),
continuous cell passage, and BAC reconstructed virus. In addition, sequences were derived for the
continuous passage virus (pU1102) and the BAC virus (BAC-U1102). The Miseq run was derived at the
same time as resequencing CiHHV6A strains 2284, 5055, and 5814 used to confirm SNPs. Consensus
sequences were determined and minor variants tabulated and quantified.
The first analyses compared the NCBI Genbank reference genome HHV-6A strain U1102 genome
to the deep sequenced early passage of the original isolate of strain U1102. In order to identify
corrections to this reference sequence, all polymorphisms subsequently identified in the passaged
strains were removed. Table 2 identifies 32 corrections to the reference sequence, including six previous
citations, and one indel (U10). Nine of these included non-synonymous coding changes with five
previously described changes (Table 2).
Table 2. Comparison of Illumina resequence human betaherpesvirus 6 (HHV-6A) U1102 to Reference
sequence NC_001664.
ORF or Locus Refseq bp Refseq:SNP
Non-Synonymous SNP
Amino Acid Change,
Codons and (Reverse
Complement Codons)
This Study or as
Cited
DR-L DR6 6663 G:GG
“ 6665 G:GG Frameshift extension [16]
DR-L repeat 7623 G:C “ “
Repeats left end U 8262 AGGAG:A
“ 8362 C:CGCG
“ 8518 T:C
“ 8559 ACAACA:CAC
“ 8591 AT:A
“ 8602 GG:G
U10 18884 C:Indel1 Frameshift extension [34,35]
U40 63871 G:T Thr:His (ACG:CAG)
“ 63872 T:G “
U42 70446 A:ATC HisCys:GlnLeuAsp(CACTGT:CAACTGCATG)
Jones & Teo 1993 in
Genbank L20954
“ 70449 G:GT “ Jones, M. inGenbank X92436
U57 mcp 92149 C:G Lys:Asn ( AAG:AAC)
U58 tbp 94068 A:G Met:Val ATG:GTG
U83 chemokine 123740 C:G AspGlu:GluGlnGACGAG:GAGCAG [15]
“ 123741 G:C “ “
U86 IE2 (128132) (Indel G) Frameshift U86/U87 In RefSeq; [17]
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Table 2. Cont.
ORF or Locus Refseq bp Refseq:SNP
Non-Synonymous SNP
Amino Acid Change,
Codons and (Reverse
Complement Codons)
This Study or as
Cited
R1 repeats 128325 C:T
“ 128443 C:T
“ 128914 G:A
“ 129917 A:ATCC
R2 repeats 132312 GG:G
R3 repeats 137831 C:G
“ 137832 G:C
“ 137906 C:G
“ 137907 G:C
U100 148154 C:G
“ 148155 G:C
U100 gQ1 149553 C:G Arg:Ala (CGT: GCT)
“ 149554 G:C “
DR-R DR6 157898 G:GG Frameshift extension
[16]“ 157900 G:GG “
DR-R repeat 158857 G:C
ORF = open reading frame; SNP = single nucleotide polymorphisms; Repetitive regions are shaded; Indel1:
CACACCTATCGCGACCCTGTTTTATGTAGAAAGAATGACAAGCCAGAACAATGA; (“) indicates same as above.
Newly identified changes were in genes U40, U57 (major capsid protein), U58, and U100 (gQ1
glycoprotein). It is possible these were mixtures of minor variants, below <1%, not detected in the
original sequence. Therefore, these were also compared to genomes from cultured passaged virus,
as well as from artificial cloned virus genomes using BACmid technology or naturally cloned virus
genome present in the germline of people with chromosomally integrated virus genomes, CiHHV6.
These were all re-sequenced at the same Illumina run, and none of these genomes showed evidence
for these SNPs screened down to 1% sensitivity by deep sequencing.
Only five further SNPs were identified from a potential mixed original population. Two were
previously described in U83 and gQ2 [13,14,27], but were not detected here down to 1% sensitivity.
A further three SNPs comprised 88–97% of the population, but in non-coding repetitive sequences
in the direct repeat (DR) region and the left end of the main unique region. The DR indels were
also identified in the integrated genomes suggesting natural variants. This confirmed 32 corrections
and 5 population variants out of 152,921 bp in the genome derived in the original isolate. Therefore,
the original Sanger sequencing of the virus isolate was 99.98% accurate, which was not possible with
Illumina next generation consensus sequencing methods, but resolved here with additional deep
sequencing and analyses of population variants.
3.2. Changes with BACmid Cloning and Reconstruction
Having established a new reference genome sequence for HHV-6A strain U1102, this was then
compared to the whole genome sequence of BACmid cloned virus. This had been cloned as BACmid
using a BACmid cassette inserted in-between genes U53 and U54 [27], then the virus was reconstructed
from tissue culture passage as described [28].
In total, 16 SNPs were identified including two indels (one in the U86 immendiate early 2 (IE2)
repeat and one in an intron of U100 gQ1). Six of those were non-synonymous changes in structural
coding genes U31 tegument, U33 capsid, U39 gB, U50 capsid, U86 IE2, and U100 gQ2 (Table 3).
The SNP in gQ2 was distinct from a polymorphism previously reported which resulted in a premature
stop codon giving a truncated gQ2 [12]. Instead, it was a single amino acid substitution (Table 3).
The only major rearrangement observed was at the site of the BAC cassette insertion. This cassette
is derived from transfer cassette pHA2 [36] and includes loxP sites bounding a gpt, BAC related and
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green fluorescent protein (GFP) genes. This was rearranged, showing all the genes deleted with only
one loxP site remaining indicative of recombination at this site. Moreover, the site of BAC insertion
interrupts a newly identified distal poly A site for the essential U53/U53A proteinase/capsid scaffold
genes (Figure 1). Therefore, mutagenic effects related to BAC reconstruction are demonstrated here.
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Figure 1. Passaged bacterial artificial chromosome (BAC)-virus deletes the green fluorescent protein
(GFP) cassette. In the BAC virus, the GFP cassette disrupts the U53/U53a transcriptional control
elements, and after tissue culture passage it is deleted. Shaded and underlined are palindrome1,
palindrome 2, and LoxP sites; note the insertion is in an end repaired EcoRI site. Underlined are the
original and new poly A regulatory sequences disrupted by the BAC cassette.
3.3. Emerging Variant Genome Populations Generated after Tissue Culture Passage
Next, using deep sequencing, the new reference HHV-6A strain U1102 genome sequence was
compared to genomes derived from virus, which had been continually passaged (four passages) as
infected cells. The results showed that the passaged virus consisted now of an expanded population of
minor variants with the now expanded major variants emerging to dominate (Table 3). Interestingly,
the variants, which arose by culture, included all the five non-synonymous SNPs in structural genes
identified in the BAC virus reconstructions. In addition, there were three further non-synonymous
mutations in replication genes. In total, there were 24 SNPs, including six indels, all non-coding, four
in DR, and one in the left end repeats of the Unique region, one in the R2 repeat and one in the intron
within U100 gQ1. The 24 SNPs ranged from 52% to 99% of the mixed population.
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Table 3. Minor variant polymorphism populations in HHV-6A U1102, passaged, and BACmid virus.
ORF or Loci RefSeqbp
RefSeq
:SNP
Amino Acid Change, Codons
and (Reverse Complement
Codons)
% New Reference % BAC Virus % Passaged Virus Comment, Citations, andOther Strains with SNPs
DR 8016 A:C - 87% - End T2
“ 8077 C:CGA 96% - -
HHV-6A AJ KP257,584.1, GS
KC465,951.1; CiHHV6A 2284
KT895,199.1, 1501
KT355,575.1; [37]; Sites
cleavages after pac2; [26,31]
“ 8080 G:GAC - 86% - CiHHV6A 2284 KT895,199.1,5055, 5814 [16,24]; “
Uleft repeat 8157 G:GC - - 78%
“ 8558 A:AC 88% AAC:A 99% 90% AC repeat
“ 8561 AAC:A - 100% 98% HHV-6A AJ [15,31]
“ 8601 CG:C 97% 87% 86%
U2 8876 G:T Ala314:Glu(GCG:GAG) - - 53%
U19 UTR 28,371 C:CA - 52% 72% HHV-6A AJ
U31 tegument 45,667 A:T Asn173:Ile AAC:ATC - 73% 96%
U33 capsid 52,148 A:G Tyr330:His(TAT:CAT) - 54% 69%
U39 gB* 61,162 T:C Thr193:Ala(ACG:GCG) - 58% 99%
U41 dbp 64,707 C:T Ala972:Thr (GCT:ACT) - - 90% HHV-6A GS KJ123,690.1
ORI repeat 67,674 T:C - - 54%
“ 67,860 T:C - - 34% HHV-6A GS KJ123,690.1 &KC465,951.1
U50 capsid 81,583 G:A Ala258:Thr(GCA:ACA) - 59% 78% HHV-6A GS KC465,951.1
“ 82,158 G:C - 67% -
U73 obp 109,214 G:A Ser297:Asn(AGT:AAT) - - 99%
U83 chemokine 123,504 G:GTT f/s N-terminal extension <1% - -
cDNA clone [13–15]; HHV-6A
AJ KP257584;
CiHHV6A: 5055 AIX09949,
23,090 AIX09956, 1501
KT355,575
U86 IE2 126,126 T:C Asn395:Asp(AAT:GAT) - - 99%
“ 127,092 C:CTGA Ser976:SerSer(TCA repeat ×9:×10) - 45% -
2 Ser insertion CiHHV6A
5055; 5814; [24]
R2 repeat 131,092 C:T - - 56% IE2 intron
“ 131,743 G:C - - 52% “
“ 131,745 A:C - - 62% “
R2 region 132,303 TG:T - 64% 56% “ TGG:T HHV-6A AJ [31]
R3 repeat 140,872 G:A - 96% - End 30× repeats from 137,775;latency IE1/2 intron [38]
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Table 3. Cont.
ORF or Loci RefSeqbp
RefSeq
:SNP
Amino Acid Change, Codons
and (Reverse Complement
Codons)
% New Reference % BAC Virus % Passaged Virus Comment, Citations, andOther Strains with SNPs
U95 142,969 T:C Trp10:Arg TGG:CGG - - 54%
“ 142,979 T:A Ile13:Asn ATT:AAT - - 53%
“ 143,591 C:A Ser217:Tyr TCC:TAC - - 76%
U100 gQ2 146,729 C:T C-terminal truncation;Trp186:stop (TGG:TGA) <1% - -
[12]1 (in 7/8 gQ2 cDNA
clones HHV-6A U1102)
“ 146,862 G:A Ser42:Leu (TCG:TTG) - 60% 99% Not in HHV-6A HHV-6AU1102 from [39]
U100 gQ1 149,251 Indel2:A intron - 44% 83% HHV-6A AJ; CiHHV6A 2284,5055, 5814 [24]
Indel2: AGGGGGGGG. Repetitive regions are shaded, DR repeats listed once here. * Adjacent to fusion loop 2 of Domain I (DI) homologue of human cytomegalovirus (HCMV) gB
C246 [40], see text. (“) indicates same as above. (–) indicates no change in comparison to the reference genome sequence.
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Almost half of the SNPs, 11/24, were shared with the SNPs in the BACmid population of
reconstructed virus genomes, therefore, indicating selection for tissue culture. These included the
non-synonymous coding changes in U31, U33, U39 gB, U50 capsid, and U100 gQ2, which are
mainly structural or envelope genes affecting infectivity. The new SNPs in this population included
non-synonymous coding changes in U2, U41 DNA binding protein, U73 origin binding protein, U86
IE2, and three in U95. There were also two SNPs within the origin for replication. Of these, only three
have been reported in another strain (GS). This strain is also a mixture from six original patients; two
SNPs were reported for GS-KJ123690.1 (U41 and origin of replication, ORI, repeat) and two SNPs for
GS-KC465951.1 (U50 capsid and the ORI repeat). The other non-coding changes are uniquely reported
here, U2, U73 origin binding protein, U86 IE2, and the three in U95, which are mainly non-structural
genes affecting replication. These may represent low-level variants present in the original virus
isolate expanded here or the effects of adaptation to tissue culture and improved replication. Notably,
all the BACmid virus SNP coding changes were present as variants in the continually passaged virus
population, identifying these as most likely tissue culture adaptations.
3.4. Virus Envelope Genes Mutations from Tissue Culture Passage Affect Fusion Complex
Both the BACmid and cultured virus accumulated mutations in envelope glycoproteins of
the entry complex, which mediate cellular fusion. This included glycoprotein gB, which has been
characterised as a fusogen conserved in herpesvirus and also gQ1 and gQ2 which are part of the
gH/gL/gQ1/gQ2 complex. Like gB, the gH/gL complexes are also conserved in herpesviruses,
but there are additional trimer or quadrameric versions in Roseolovirus. The gH/gL/gQ1/gQ2
components are specific to Roseoloviruses; this complex interacts with a cellular receptor CD46, and is
a target for a neutralising antibody, which inhibits cellular spread [11,41,42]. These genes are positional
homologues of the UL128/130/131 pentameric complexes in HCMV which are also mutated by virus
passage in cell culture [43]. The remaining complex gH/gL/gO is unaltered from tissue culture of both
viruses. Although at present there is not a structural model for gQ1 or gQ2, the complex interacting
with gH/gL can form the fusion complex as for other herpesviruses [12].
There are crystal structures available for homologous gB molecules from HCMV, HSV, and EBV
(see Material and Methods) in the post-fusion conformation [40,44]. Using these structures,
we modelled the tertiary structure of HHV-6A U1102 gB affected by the mutation Thr193Ala from
cell passage (Table 3, Figures 2 and 3). This mutation is not found in any homologous gB sequence
analysed to date (BLAST Genbank scans). Alignments show that this mutation is located in the Beta
12 pleated sheet of Domain I (DI) of gB (based on the HCMV homolog) in the vicinity of the second
fusion loop, FL2 (residues 184–191; Figure 2 and see Figures S1–3). Thr193 aligns to the unpaired
Cys246 residue in HCMV gB. Further, DI not only is the fusion domain, but also the site suggested of
interaction with gH/gL in potential triggering of cell fusion [40]. Thr193 is conserved in HSV and EBV
gB next to a conserved motif central to the beta sheet (Figures 2 and 3).
The passage mutation Thr193Ala is unlikely to affect the beta sheet prediction adjacent to FL2
(beta sheet 12 in HCMV domain I), but the reduced polar residues away from FL2 and increased
hydrophobicity may promote membrane association via the Domain I structure as the mutation is
within the FL2 adjacent beta-strand (Figures 2 and 3). However, this residue seems to be interacting
with residues at the trimer interfaces in Domain I (Leu93, Phe95, Ala147, Asp151, Thr191, and Leu195)
(Figure 3 and Figure S2). Alternatively, the Thr193Ala mutation may modify the angle of inclination of
the beta-sheet, increasing the interaction between the fusion loops and the membrane, although more
likely stabilising the subunit interactions in the hydrophobic pocket as shown by increases in stability
predictions (Figure S2).
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domain I [40]. Alignments were made using Clustal as described [40] with gB from HCMV (shown 
for strains Merlin, Towne, and TB40E and 74 clinical strains; strain AD169 and six clinical strains have 
Val252Leu), EBV (strain B958), and HSV-1 (strain KOS) (UniProtKB P06473, Q777B0, P06437, 
respectively). The FL2 in HCMV, EBV, and HSV-1 gB are in bold, and predicted FL2 for HHV-6A/B 
and HHV-7 are similarly indicated. FL2 in HHV-6A/B gB is amino acids 184–191 and in HCMV, strain 
Merlin, 237–244. This is adjacent to a conserved beta sheet shown in the structures of EBV, HSV, and 
cytomegalovirus (CMV) gB as underlined, and that predicted for HHV-6A/B and HHV-7 indicated 
(See Methods). The Thr193Ala passage SNP is shaded in the FL2 adjacent region, disrupting the polar 
patch and increasing hydrophobicity. This Thr is conserved in HHV-6A/B, HHV-7, EBV, and HSV. 
Figure 2. Human herpesvirus gB fusion loop 2, FL2, region sequence comparisons show unique SNP
substitution in passaged HHV-6A virus. Comparison of the FL2 (in bold) and associated sequences
of HHV-6A gB (residues 184–191 in FL2 in bold) from passaged virus (and cultured BAC virus)
compared to gB from 51 clinical samples of HHV-6A/B [45], CiHHV-6A/B [14,24], and 50 clinical
samples of HHV-7 gB [46] demonstrating the Thr193Ala mutation is only found in passaged virus.
This is compared to reference sequences from alpha, beta, and gamma herpesvirus gB where the
structure has been determined, as shown for HCMV gB structure, identifying the beta sheet 12 in
domain I [40]. Alignments were made using Clustal as described [40] with gB from HCMV (shown
for strains Merlin, Towne, and TB40E and 74 clinical strains; strain AD169 and six clinical strains
have Val252Leu), EBV (strain B958), and HSV-1 (strain KOS) (UniProtKB P06473, Q777B0, P06437,
respectively). The FL2 in HCMV, EBV, and HSV-1 gB are in bold, and predicted FL2 for HHV-6A/B
and HHV-7 are similarly indicated. FL2 in HHV-6A/B gB is amino acids 184–191 and in HCMV, strain
Merlin, 237–244. This is adjacent to a conserved beta sheet shown in the structures of EBV, HSV, and
cytomegalovirus (CMV) gB as underlined, and that predicted for HHV-6A/B and HHV-7 indicated
(See Methods). The Thr193Ala passage SNP is shaded in the FL2 adjacent region, disrupting the polar
patch and increasing hydrophobicity. This Thr is conserved in HHV-6A/B, HHV-7, EBV, and HSV.
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HHV-6A U1102 isolate in comparison to cell culture adapted virus and cell culture reconstructed
BACmid virus. We also compared it to natural “clones” of HHV-6A in the integrated CiHHV-6A
genomes we previously derived and re-sequenced here. Specifically, 32 SNP corrections were made to
the reference genome sequence, which included nine corrections previously reported (Table 2) giving
an overall original accuracy of 99.98%, higher than that of consensus sequencing by Illumina which
is 99%. However, combined with deep sequencing of the original isolate, this allowed enhanced
resolution as well as definition of emerging minor variants in the cell culture passaged virus, and many
of these dominated the mixed population and were detected as “major” variants. There were mixtures
of variants in both the passaged HHV-6A U1102 and BAC-U1102 virus stocks with 34–99% mixtures
compared to the redefined reference genome. In the passaged stocks, HHV-6A pU1102 and BAC-U1102,
there were 10 and 6 genes with non-synonymous SNPs, respectively. Therefore, both the HHV-6 pU1102
and BAC-HHV-6-U1102 stock viruses had polymorphic mixtures. This also is the first derivation of
the genome of the reconstructed BAC-HHV-6-U1102 and the polymorphisms shown here comprise a
subset of those in the passaged virus, identifying cell culture specific effects.
The passaged stocks were shown comprised of complex polymorphic mixtures, with SNPs
averaging 50% mixtures with the wild type reference virus genome. We used screens to the 85 defined
coding genes as described for both virus and integrated genomes [24,26]. There were SNP mixtures in
both the passaged virus stock as well as the cloned BACmid virus stocks. The passaged virus had 24
SNPs identified.
Mixtures and variants of the strains of HHV-6A as well as related HHV-6B have been described
previously. In these cases, the dominant SNP created the consensus sequence. The initial virus isolates
from patients were not clonal and since the virus is cell associated, the virus strains were not clone
purified previously. For example, there are at least two consensus genomes for HHV-6A strain GS [47]
(HHV-6A GS KJ123,690.1 and KC465,951.1).
Using BACmid technology, which “clones” the virus genome using a bacterial artificial
chromosome sequence, BAC, with plasmid elements, this should clonally purify the virus stock.
However, recovered virus has to replicate in cell culture, and studies from another herpesvirus, HCMV,
show that complex mixtures of SNPs can accumulate during selection for replication in tissue culture.
In the case of the only described HHV-6A BACmid, BAC-U1102, we also show here there are SNPs
compared to the wild type genome. Some could be present in the virus stock used to generate this
BAC, but the mixtures shown here also indicate there is some selection during growth in culture.
In the original description of the derivation of BAC HHV-6A U1102, four clones showed varying
BAMH1 restriction endonuclease digestion profiles, indicating either mixtures present in the parent
U1102 stock used or mutagenesis during the derivation of the BACmid clones. Notably, only one
of these clones, G1, was able to reconstitute virus after transfection and co-culture with cord blood
mononuclear cells (CBMC). This BAMH1 restriction enzyme profile most closely resembles that
reported for the original isolate [19,48]. However, reports using this BAC cloned virus have observed
low replication efficiency, so it is possible that the SNPs identified here contribute to this phenotype.
It is notable that there are fewer SNPs in the parent BACmid stock, 16 SNPs compared to 24 in the
passaged HHV-6 U1102 stock, which could indicate that continuous passage of virus in culture permits
accumulation of further SNPs.
Rearrangements in the BACmid may also affect virus replication efficiency. The BAC virus
genomes had deletion of the GFP gene. Only the recombined loxP site and associated sequences from
the original vectors were maintained in both the parent BAC and the K21 treated BAC virus. Although
this could be from homologous recombination mediated by the host, the efficient rearrangement in the
entire population suggests a virus gene product is mediating this event. This would confound any
selection process dependent on GFP, since mutations or rearrangements would have to occur to reduce
this activity. Since GFP expression has been used to characterise genome integration, it is likely that
selection for GFP may be artificially enhancing integration as demonstrated [49–51]. Analyses showed
that the GFP insertion disrupts utilisation of the downstream polyadenylation site, which could be a
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more efficient transcript. The upstream polyadenylation signal is prior to the stop codon, and with
cleavage 10–30 nucleotides downstream, this could result in transcript cleavage and polyadenylation
before the stop codon, resulting in an unstable transcript. This could affect the interpretation of studies
using BACmids to study replication or integrations. For example, if GFP is selected, this could select for
virus with inefficient virus replication, and promote virus genome integration. Further, the remaining
bacterial origin sequences may affect replication and integration. The GFP insertion may interrupt
the alternate downstream polyadenylation site, giving inefficient expression of the essential scaffold
protein p53A and lower virions. Therefore, use of this BACmid for replication or integration studies
can give confounding results and either new non-rearranging BACmid or different approaches are
required to understand these pathways.
The SNPs in BACmid reconstructed virus are shared with those in the passaged virus, showing
effects of cell culture passage, and all are in structural genes. In comparison, the virus-passaged
genomes had only three additional SNPs, all related to replication, in the origin binding protein,
and the immediate early genes IE2 and U95 “IE3”. There were five shared structural changes, two in
capsid and tegument genes, U31 and U33, with the remaining three in envelope glycoprotein genes
affecting virus cellular entry by cell fusion. These included gB and the gH/gL complex components
gQ1 and gQ2. These may be culture adapted changes for improved growth in leukemic cell lines
JJhan, SupT1, and HSB2, which may affect the selection. In contrast, clinical isolates were prepared
on primary cord blood stem cells. The population of BACmid SNPs were in structural genes and the
virus envelope and these, including gB Thr193Ala, were all contained in the passaged population of
SNPs, which also included SNPs in essential replication genes. Of particular relevance, we showed
treatment of BAC virus with a novel antiviral affected membranes, reverted the population to wild
type, and eliminated the cell culture passage SNPs in the envelope glycoproteins [29].
In HCMV, cell culture causes changes in the virus entry complex, specifically in components
of the pentameric complex of gH/gL, in UL128, UL130, and UL131. In HHV-6A, the genes in the
homologous genomic position also encode a fusion complex alternate to the trimeric gH/gL/gO.
This is the quadrameric complex of gH/gL including components gQ1 and gQ2. In addition, there
is a chemokine gene, a virokine, U83A, which is the positional homologue of UL128, but appears to
independently direct cellular recruitment for dissemination or immune evasion. There is polymeric
DNA editing polymorphism in this gene disrupting expression, the full-length gene is only rarely
identified in culture, but has been identified in “cloned” integrated genomes [14]. Therefore, effects of
cell passage of both virus and BAC virus show similarities to the mutations arising in HCMV after
cell culture passage. The gH/gL/gQ1/gQ2 complex binds the receptor CD46, and it appears that in
HHV-6A cell culture, passage favours mutation of the alternate complex to gH/gL/gO, which may
also distort cellular tropism and immune responses as shown for CMV. Distinct from HCMV, we show
virus and BAC-virus laboratory passage also results in mutation of the fusogen gB, in addition to the
fusion regulator, the gH/gL complexes.
HHV-6A gB is closely related to HCMV gB, which enabled modelling of the ectodomain in the
post-fusion conformation with high confidence. This demonstrated the mutation, Thr193Ala, was in
Domain I, which mediates cell fusion, specifically in proximity to the fusion loop 2 (FL2) adjacent
region within a conserved beta sheet. Interestingly, recent studies identified a cell culture induced
mutation in the Ebola virus GP1,2 glycoprotein, which increases virus cellular spread. This is also
in the fusion loop adjacent region, a Thr544Ile mutation, which also increases hydrophobicity [52].
The modelling of HHV-6 gB mutation showed that the mutation is located at the predicted trimer
interface region, which may increase the stability of the post-fusion conformation through increased
hydrophobicity (Figure S2). Interestingly, in treatment with a membrane directed antiviral, the treated
virus no longer retained the gB mutation, and comparisons with the mutated passaged virus in immune
precipitation analyses did show increased stability of gB [28,29].
The cell culture passage mutation in the FL2 proximal region is within domain I, the site of effects
by gH/gL based on experimental results, although no stable intermediate has been identified [40].
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In HSV gH, the N-terminal region proposed to affect gB overlaps with the site of gL interaction and
a complex conformational epitope, interacting with a neutralising LP11 antibody [53,54]. A similar
structure has been demonstrated at the N-terminus of HHV-6A gH, with mutational analyses
demonstrating that a conformational change between interactions of the N and C terminal domains
is required for cell fusion [8]. Campadelli-Fiume and colleagues have demonstrated that for the
HSV entry complex, gL removal is required for fusion [55]. Therefore, the cell passage mutation in
the HHV-6A FL2 proximal region in gB domain I could potentially affect this cell fusion regulation
favouring cell-associated virus spread. Recent studies on the gB fusion loops indicate the FL2 proximal
region may influence the angle of membrane association [56].
Taken together, our overall studies have redefined the reference genome and identified SNPs
associated with cell culture and BAC virus passage, which can affect virus infection by cell fusion as
similarly demonstrated in the related betaherpesvirus HCMV. Characterisation of host interactions,
genome integration, immune interactions, and antiviral resistance all need to take account of the
effects of a diverse mixed genome population present in laboratory-passaged virus and highlight the
components of the virus entry complex affecting cellular spread.
5. Conclusions
The reference virus genome was re-defined by deep sequencing of the early clinical isolate. Tissue
culture passaged virus accumulated a population of genetic variants in genes affecting infection and
replication. Virus culture of BACmid virus accumulated a subset of these SNPs in genes affecting
infection, including envelope genes gB and gQ1 and gQ2 of the gH/gL complex. Efforts to study
virus properties need to focus on the newly defined reference strain. New BACs or different culturing
protocols may be required to do this. Additional study of these cell associated mutations from BAC
and passaged virus would provide further understanding of cell associated infection and regulation of
virus production versus integration.
Supplementary Materials: The following are available online at www.mdpi.com/1999-4915/10/1/16/s1, Figure
S1: Alignment HHV-6A strain U1102 and HCMV strain Merlin gB ectodomains; Figure S2: The passage mutation
in HHV-6 gB incrases interface hydrophobicity affecting subunit interactions; Figure S3: Multiple sequence
alignment of HHV-6A gB with model templates from HCMV, HSV and EBV.
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